Axsome Therapeutics, Inc. (AXSM)
182.55
+1.71
(+0.95%)
USD |
NASDAQ |
Feb 06, 16:00
183.00
+0.45
(+0.25%)
Pre-Market: 09:16
Axsome Therapeutics Total Assets (Quarterly) : 669.25M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Gilead Sciences, Inc. | 58.53B |
| Vanda Pharmaceuticals, Inc. | 601.14M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Amicus Therapeutics, Inc. | 868.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 595.52M |
| Shareholders Equity (Quarterly) | 73.73M |
| Debt to Equity Ratio | 2.965 |
| Current Ratio | 1.569 |
| Net Debt Paydown Yield | -0.09% |